Use of statistics to assess the global burden of breast cancer

Breast Journal

Volumn 12, Issue SUPPL. 1, 2006, Pages

  Parkin, D Maxwell ^a   Fernández, Leticia M G ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL INSTITUTE OF ONCOLOGY   (Cuba)

Author keywords

Breast cancer; Burden of illness; Health care evaluation mechanisms; Health planning; Outcomes assessment; Program evaluation; Registries; Resource allocation; Statistics

Indexed keywords

HORMONE;

BREAST CANCER; BREAST FEEDING; CANCER CONTROL; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIETARY INTAKE; DYING; EARLY CANCER; EARLY DIAGNOSIS; EXPOSURE; FEMALE; HUMAN; LIFESTYLE; MAMMOGRAPHY; OBESITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; QUALITY CONTROL; REVIEW; RISK FACTOR; STATISTICAL ANALYSIS;

BREAST NEOPLASMS; DATA INTERPRETATION, STATISTICAL; FEMALE; HEALTH PLANNING; HUMANS; REGISTRIES; WORLD HEALTH;

EID: 33644889948     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2006.00205.x     Document Type: Review

References (59)

1. Parkin DM Bray FI. Descriptive studies In Ahrens W Pigeot I eds Handbook of Epidemiology Berlin Springer 2004
2. Pisani P Bray F Parkin DM. Estimates of the worldwide prevalence of cancer for 25 cancers in the adult population Int J Cancer 2002 97 72 81
3. Parkin DM Bray FI. International patterns of cancer incidence and mortality In Schottenfeld D Fraumeni JF Jr. eds Cancer Epidemiology and Prevention 3rd ed New York Oxford University Press in press
4. Parkin DM Whelan SL Ferlay J Storm H. Cancer Incidence in Five Continents vols. I-VIII. IARC CancerBase no. 6 Lyon, France IARC Press 2005 Available at ; accessed September 27, 2005
5. Ries LAG Eisner MP Kosary CL et al. eds SEER Cancer Statistics Review Bethesda, MD National Cancer Institute 2004 1975 2001 Available at ; accessed April 11, 2005
6. Sant M Aareleid T Berrino F et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94 - results and commentary Ann Oncol 2003 14 suppl. 5 v61 118
7. Sankaranarayanan R Black RJ Parkin DM eds Cancer Survival in Developing Countries Scientific publication no. 145 Lyon, France IARC Press 1998
8. Ferlay J Bray F Pisani P Parkin DM. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. IARC CancerBase no. 5, version 2.0 [data on CD-ROM] Lyon, France IARC Press 2004
9. Parkin DM Bray F Ferlay J Pisani P. Global cancer statistics, 2002 CA Cancer J Clin 2005 55 74 108
10. IARC Working Group on the Evaluation of Cancer-Prevention Strategies. Handbooks of Cancer Prevention vol. 7 Breast Cancer Screening Lyon, France IARC Press 2002
11. Hewitt M Breen N Devesa S. Cancer prevalence and survivorship issues: analyses of the 1992 National Health Interview Survey J Natl Cancer Inst 1999 91 1480 86
12. McPherson K Steel CM Dixon JM. Breast cancer - epidemiology, risk factors and genetics BMJ 2000 321 624 28
13. Geddes M Parkin DM Khlat M Balzi D Buiatti E eds Cancer in Italian Migrant Populations Scientific publication no. 123 Lyon, France IARC Press 1993
14. Tyczynski J Tarkowski W Parkin DM Zatonski W. Cancer mortality among Polish migrants to Australia Eur J Cancer 1994 30A 478 84
15. Ziegler RG Hoover RN Pike MC et al. Migration patterns and breast cancer risk in Asian-American women J Natl Cancer Inst 1993 85 1819 27
16. Kelsey JL Bernstein L. Epidemiology and prevention of breast cancer Annu Rev Public Health 1996 17 47 67
17. Parkin DM. Cancers of the breast, endometrium and ovary: geographic correlations Eur J Cancer Clin Oncol 1989 25 1917 25
18. Bergström A Pisani P Wolk A Adami HO. Overweight as an avoidable cause of cancer in Europe Int J Cancer 2001 91 421 30
19. Brinton LA Benichou J Gammon MD Brogan DR Coates R Schoenberg JB. Ethnicity and variation in breast cancer incidence Int J Cancer 1997 73 349 55
20. Bray F McCarron P Parkin DM. The changing global patterns of female breast cancer incidence and mortality Breast Cancer Res 2004 6 229 39
21. Botha JL Bray F Sankila R Parkin DM. Breast cancer incidence and mortality trends in 16 European countries Eur J Cancer 2003 39 1718 29
22. Quinn M Allen E. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. United Kingdom Association of Cancer Registries BMJ 1995 311 1391 95
23. Persson I Bergstrom R Barlow L Adami HO. Recent trends in breast cancer incidence in Sweden Br J Cancer 1998 77 167 69
24. Zaridze DG Basieva TH. Incidence of cancer of the lung, stomach, breast, and cervix in the USSR: patterns and trends Cancer Causes Control 1990 1 39 40
25. Nab HW Mulder PG Crommelin MA van der Heijden LH Coebergh JW. Is the peak in breast cancer incidence in sight? A study conducted in the southeastern Netherlands Eur J Cancer 1994 30A 50 52
26. Walter SD Day NE. Estimation of the duration of a pre-clinical disease state using screening data Am J Epidemiol 1983 118 865 86
27. Lacey JV Jr. Devesa SS Brinton LA. Recent trends in breast cancer incidence and mortality Environ Mol Mutagen 2002 39 82 88
28. Wun LM Feuer EJ Miller BA. Are increases in mammographic screening still a valid explanation for trends in breast cancer incidence in the United States? Cancer Causes Control 1995 6 135 44
29. Weir HK Thun MJ Hankey BF et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control J Natl Cancer Inst 2003 95 1276 99
30. Smigel K. Breast cancer death rates decline for white women [news] J Natl Cancer Inst 1995 87 173
31. National Cancer Institute of Canada. Canadian Cancer Statistics 1998 Toronto, Ontario, Canada National Cancer Institute of Canada 1998
32. Giles GG Amos A. Evaluation of the organised mammographic screening programme in Australia Ann Oncol 2003 14 1209 11
33. Armstrong W Borman B. Breast cancer in New Zealand: trends, patterns, and data quality N Z Med J 1996 109 221 24
34. Smith CL Kricker A Armstrong BK. Breast cancer mortality trends in Australia: 1921-94 Med J Aust 1998 168 11 14
35. Wakai K Suzuki S Ohno Y Kawamura T Tamakoshi A Aoki R. Epidemiology of breast cancer in Japan Int J Epidemiol 1995 24 285 91
36. Nagata C Kawakami N Shimizu H. Trends in the incidence rate and risk factors for breast cancer in Japan Breast Cancer Res Treat 1997 44 75 82
37. Parkin DM. Cancer in developing countries Cancer Surveys 1994 19/20 519 61
38. Coleman MP Esteve J Damiecki P Arslan A Renard H. Trends in Cancer Incidence and Mortality Lyon, France IARC Press 1993
39. Yeole BB Kurkure AP. An epidemiological assessment of increasing incidence and trends in breast cancer in Mumbai and other sites in India, during the last two decades Asian Pac J Cancer Prev 2003 4 51 56
40. Seow A Duffy SW McGee MA Lee J Lee HP. Breast cancer in Singapore: trends in incidence 1968-1992 Int J Epidemiol 1996 25 40 45
41. Yang L Parkin DM Li L Chen Y. Time trends in cancer mortality in China: 1987-1999 Int J Cancer 2003 106 771 83
42. Chie WC Chen CF Lee WC Chen CJ Lin RS. Age-period cohort analysis of breast cancer mortality Anticancer Res 1995 15 511 15
43. Leung GM Thach TQ Lam TH et al. Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an age-period-cohort analysis Br J Cancer 2002 87 982 88
44. Parkin DM Ferlay J Hamdi-Cherif M et al. eds Cancer in Africa: Epidemiology and Prevention Scientific publication no. 153 Lyon, France IARC Press 2003
45. Wabinga HR Parkin DM Wabwire-Mangen F Nambooze S. Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997 Br J Cancer 2000 82 1585 92
46. Shapiro S Coleman EA Broeders M et al. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening Int J Epidemiol 1998 27 735 42
47. International Agency for Research on Cancer. Breast Cancer Screening Lyon, France IARC Press 2002
48. McCann J Stockton D Day N. Breast cancer in East Anglia: the impact of the breast screening programme on stage at diagnosis J Med Screen 1998 5 42 48
49. Hakama M Pukkala E Heikkila M Kallio M. Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study BMJ 1997 314 864 67
50. Tabar L Fagerberg G Duffy SW Day NE Gad A Grontoft O. Update of the Swedish two-county program of mammographic screening for breast cancer Radiol Clin North Am 1992 30 187 210
51. Kricker A Farac K Smith D Sweeny A McCredie M Armstrong BK. Breast cancer in New South Wales in 1972-1995: tumor size and the impact of mammographic screening Int J Cancer 1999 81 877 80
52. Blanks RG Moss SM McGahan CE Quinn MJ Babb PJ. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-1998: comparison of observed with predicted mortality BMJ 2000 321 665 69
53. Jatoi I Miller AB. Why is breast-cancer mortality declining? Lancet Oncol 2003 4 251 54
54. Chlebowski RT Collyar DE Somerfield MR Pfister DG. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene J Clin Oncol 1999 17 1939 55
55. Peto R Boreham J Clarke M Davies C Beral V. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years [correspondence] Lancet 2000 355 1822
56. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials Lancet 1998 351 1451 67
57. Chu KC Tarone RE Kessler LG et al. Recent trends in US breast cancer incidence, survival, and mortality rates J Natl Cancer Inst 1996 88 1571 79
58. Peto R. Five years of tamoxifen - or more? J Natl Cancer Inst 1996 88 1791 93
59. Selby P Gillis C Haward R. Benefits from specialised cancer care Lancet 1996 348 313 18